Due to its significant applicability for early detection, risk prediction and follow-up evaluation,
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …

In the 1990s the discovery of prostate-specific antigen (PSA) revolutionized early prostate
cancer detection. Since that time, PSA has become an indispensable marker for diagnosis …

INTRODUCTION: Due to its universal applicability for early detection and prediction of
cancer stage and disease recurrence, widespread implementation of serum-based prostate …

Prostate-specific antigen (PSA) is widely used as a biomarker in the detection of prostate
cancer and for decision making regarding treatment options, response to therapy, and …

The introduction of prostate-specific antigen (PSA) revolutionized prostate cancer (PCa)
screening and ushered the PSA era. However, its use as a screening tool remains …

The widespread use of the PSA test has led to increased detection of the disease at earlier
stages and a reduction in the number of patients where metastatic disease is found at …

Prostate specific antigen (PSA) is one of the best-known biomarkers for screening, diagnosis
and follow-up of patients for prostate cancer. Owing to several inherent limitations with PSA …

Prostate cancer is the most noncutaneous malignancy diagnosed in men in the USA. The
discovery of prostate-specific antigen (PSA) revolutionized prostate cancer diagnosis and …

Although prostate cancer (PCa) is the most commonly diagnosed cancer in men, most
patients do not die from the disease. Prostate specific antigen (PSA), the most widely used …

Background The use of biomarkers for prostate cancer screening, diagnosis and prognosis
has the potential to improve the clinical management of the patients. Owing to inherent …